Compounds > 1-hexadecyl-2-acetyl-glycero-3-phosphocholine
Page last updated: 2024-09-02

1-hexadecyl-2-acetyl-glycero-3-phosphocholine and oleanolic acid

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with oleanolic acid in 3 studies

Compound Research Comparison

Studies
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)		Trials
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)		Recent Studies (post-2010)
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)		Studies
(oleanolic acid)		Trials
(oleanolic acid)		Recent Studies (post-2010) (oleanolic acid)
9,1561875524,169312,404

Protein Interaction Comparison

ProteinTaxonomy1-hexadecyl-2-acetyl-glycero-3-phosphocholine (IC50)oleanolic acid (IC50)
Aldo-keto reductase family 1 member B10Homo sapiens (human)2.045
Phospholipase A2Homo sapiens (human)3
DNA polymerase betaHomo sapiens (human)6.8667
DNA polymerase betaRattus norvegicus (Norway rat)5.6
Receptor-type tyrosine-protein phosphatase CHomo sapiens (human)1
Receptor-type tyrosine-protein phosphatase FHomo sapiens (human)3.065
Tissue factorHomo sapiens (human)0.005
Tyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)4.38
Tyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)2.8444
Liver carboxylesterase 1Homo sapiens (human)0.1
Tyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)3.065
M-phase inducer phosphatase 2Homo sapiens (human)0.98
Dual specificity protein phosphatase 3Homo sapiens (human)5.4
Transcription factor p65Homo sapiens (human)2.4
Tyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)3.065
Protease Human immunodeficiency virus 18

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (66.67)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Fang, J; Zheng, QY1
Ishihara, K; Ito, K; Kosuge, E; Kuriyama, M; Nakamura, T1
Cao, L; Fang, Z; Jia, D; Mi, J; Pan, Z; Peng, P; Shi, Z; Zhang, Y1

Other Studies

3 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and oleanolic acid

ArticleYear
[Inhibitory effect of esculentoside A on platelet activating factor released from calcimycin induced rat peritoneal macrophages].
    Yao xue xue bao = Acta pharmaceutica Sinica, 1991, Volume: 26, Issue:10

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Calcimycin; Dose-Response Relationship, Drug; Drugs, Chinese Herbal; Female; Macrophages; Male; Oleanolic Acid; Peritoneal Cavity; Platelet Activating Factor; Rabbits; Rats; Rats, Inbred Strains; Saponins

1991
Effects of saiboku-to (TJ-96) on the production of platelet-activating factor in human neutrophils.
    Annals of the New York Academy of Sciences, 1993, Jun-23, Volume: 685

    Topics: Drugs, Chinese Herbal; Glycyrrhetinic Acid; Glycyrrhizic Acid; Humans; Immunosuppressive Agents; Medicine, Kampo; Neutrophils; Oleanolic Acid; Platelet Activating Factor; Sapogenins; Saponins

1993
α-Hederin inhibits the platelet activating factor-induced metastasis of HCC cells through disruption of PAF/PTAFR axis cascaded STAT3/MMP-2 expression.
    Pharmacological research, 2022, Volume: 178

    Topics: Carcinoma, Hepatocellular; Cell Line, Tumor; DNA-Binding Proteins; Humans; Liver Neoplasms; Matrix Metalloproteinase 2; Molecular Docking Simulation; Neoplasm Metastasis; Oleanolic Acid; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, G-Protein-Coupled; Saponins; Signal Transduction; STAT3 Transcription Factor

2022